Also from this source

You just read:

Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

Dec 08, 2010, 09:00 EST